SFE Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
AFG
SFE Investment Counsel's IBB Position: Q2 2026 in Review
SFE Investment Counsel reduced its iShares Biotechnology ETF (IBB) stake by 1.7% in Q2 2026, selling an estimated $6.36K and leaving 2,131 shares worth $405K. The position accounts for 0.05% of the portfolio, ranked #115.
SFE Investment Counsel first reported a position in IBB in Q1 2022 and has held it in 18 quarters since. The position peaked at $505K in Q1 2022. 601 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- SFE Investment Counsel held 2,131 shares of iShares Biotechnology ETF worth $405K as of Q2 2026.
- SFE Investment Counsel sold 37 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.36K.
- iShares Biotechnology ETF made up 0.05% of SFE Investment Counsel's portfolio in Q2 2026, its #115 holding.
- SFE Investment Counsel first reported a position in iShares Biotechnology ETF in Q1 2022 and has held it in 18 quarters since.
- SFE Investment Counsel's iShares Biotechnology ETF position peaked at $505K in Q1 2022.
- 601 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on SFE Investment Counsel's 13F filing for Q2 2026, filed 5 Aug 2026.